top of page
Arstat Pharmaceuticals
Advancing Transformational Products for Tens of Millions of Women
Our Portfolio
One of the Best Portfolios in Women’s Health
Fourteen US and EU patents, two Phase III-ready products,
two likely blockbusters
TM
The first and only
contraceptive endorsed by the FDA for exclusive testing and labeling for women with overweight and obesity
(≈20 million US contraceptive users)
Addressing a high public health priority in the post-Roe world
TM
First-in-category
medicated vaginal ring for uterine fibroids and endometriosis
(>15 million US women)
Designed to drastically reduce the need for radical surgeries
TM
First-in-category
single non-hormonal therapy for painful, heavy menstrual periods
(>25 million US women)
A potential treatment of choice for a common menstrual disorder
Mission
Develop Safe and Effective Solutions for Highly Prevalent, Under-treated Reproductive Conditions and Disorders
​
Contact Us
bottom of page